We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
NUVO - Division of Medical Illumination

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
08 Jun 2023 - 10 Jun 2023

Mechanical Nanosurgery Uses Nanotechnology and Precision Magnetics to Destroy Therapy-Resistant Brain Cancers

By HospiMedica International staff writers
Posted on 12 Apr 2023
Print article
Image: Mechanical nanosurgery targets tumor cells and destroy them from within (Photo courtesy of SickKids)
Image: Mechanical nanosurgery targets tumor cells and destroy them from within (Photo courtesy of SickKids)

Glioblastoma (GBM) is the most prevalent and aggressive form of primary brain cancer. Although various treatments, such as surgery, radiotherapy, and chemotherapy, are available, patients' median survival time is only about 15 months. The global standard-of-care for GBM patients currently involves chemotherapy with a drug called temozolomide (TMZ), which prolongs life expectancy by approximately two months compared to radiotherapy alone. However, GBM cells can become resistant to TMZ, diminishing its effectiveness and increasing the chances of tumor recurrence. In response, researchers are exploring an innovative method called mechanical nanosurgery, which uses precision magnetics to target cancer cells within the tumor.

Scientists at The Hospital for Sick Children (SickKids, Toronto, ON, Canada) and the University of Toronto (U of T, Toronto, ON, Canada) are collaborating to develop mechanical nanosurgery as a potential treatment for tumor cells, including those resistant to chemotherapy. Magnetic carbon nanotubes (mCNTs) are a type of nanomaterial—microscopic, cylindrical tubes made of carbon and filled with iron—that become magnetized when exposed to an external magnetic field.

In their study, the researchers coated mCNTs with an antibody that identifies a specific protein associated with GBM tumor cells. When injected into the tumor, the antibodies on the mCNTs guide them to the tumor cells, which then absorb them. The team's ongoing research suggests that mechanical nanosurgery could have additional applications in treating other cancer types. The study's mouse model demonstrated that the mechanical nanosurgery technique universally reduced GBM tumor size, including in cases of TMZ-resistant GBM.

“Once the nanotubes are inside the tumor cell, we use a rotating magnetic field to mechanically mobilize the nanotubes to provide mechanical stimulation,” said Dr. Yu Sun, Professor of Mechanical Engineering and Director of the Robotics Institute at U of T. “The force exerted by the nanotubes damages cellular structures and cause tumor cell death.”

“Through the use of nanotechnology deep inside cancer cells, mechanical nanosurgery is a ‘Trojan Horse’ approach that could allow us to destroy tumor cells from within,” said Dr. Xi Huang, a Senior Scientist in the Developmental & Stem Cell Biology program at SickKids, whose previous research demonstrating that brain tumor cells are mechanosensitive helped to inform the approach. “Theoretically, by changing the antibody coating and redirecting nanotubes to the desired tumor site, we could potentially have a means to precisely destroy tumor cells in other cancers.”

Related Links:
U of T

Gold Supplier
Portable X-Ray System
FDR Xair
Patient Positioning Devices & OR Accessories
SchureMed Tools
Mobile X-Ray Table
X Mobil
IV Medication Safety Software
ICU Medical MedNet IV

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: The novel intravascular, catheter-based technology is designed to treat pulmonary hypertension (Photo courtesy of Freepik)

Minimally Invasive Catheter-Based Technology Treats Pulmonary Hypertension

Pulmonary hypertension, a deadly condition impacting roughly 500,000 patients annually across the world, is currently categorized as a rare disease. As it stands, available treatment options are restricted,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: VCM viscoelastic testing instrument provides rapid, real-time hemostasis assessment at POC (Photo courtesy of Entegrion)

Next Gen Viscoelastic Coagulation Monitor Enables Rapid Hemostasis Assessment at Patient Side

The use of viscoelastic coagulation testing is on the rise for various applications such as trauma, surgery, obstetrics, major disease management, and more. It provides crucial information not obtained... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.